Close Menu

Luminex

NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.

NEW YORK (GenomeWeb News) – Nanosphere today said that its second-quarter revenues jumped 160 percent year over year, but the firm fell short of Wall Street's estimate for the top line.

NEW YORK (GenomeWeb News) – Luminex has completed the acquisition of molecular diagnostics firm GenturaDx for $50 million in cash plus potential additional consideration based on milestones and/or product revenue performance.

Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.

NEW YORK (GenomeWeb News) – Luminex has signed a definitive agreement to acquire molecular diagnostics firm GenturaDx for $50 million in cash and potential additional consideration based on milestones and/or product revenue performance.

NEW YORK (GenomeWeb News) – While there is widespread concern about potential cutbacks in federal spending for research both in the US and abroad, that concern did little to dampen the stock performance of many of the firms in the GenomeWeb Daily News Index in the first half of 2012.

NEW YORK (GenomeWeb News) – Though it was a mixed month on the stock market for firms in the genomic tools and molecular diagnostics industries, Nanosphere and Cepheid managed significant gains, while Complete Genomics continued to struggle.

NEW YORK (GenomeWeb News) – Investment firm Jefferies today upgraded Nanosphere's stock to Buy, driving the firm's shares up 27 percent to $3.20 in Tuesday morning trading.

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

The University of Florida Academic Health Center this week launched a new personalized medicine effort in which all patients visiting its catheterization lab will receive a multi-gene test that will be used to discern whether they are likely to respond to the anti-platelet drug c

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.